Animal modelling with the Francisella tularensis subspecies holarctica strain OR96-0246
Authors:
- Kevin D. MlynekKMKevin D. Mlynek
- Sara I. RuizSRSara I. Ruiz
- Curtis R. ClineCCCurtis R. Cline
- Alexandra N. JayAJAlexandra N. Jay
- Ju QiuJQJu Qiu
- Ronald G. ToothmanRTRonald G. Toothman
- Elsie E. MartinezEMElsie E. Martinez
- Wannaporn IttiprasertWIWannaporn Ittiprasert
- Nancy A. TwenhafelNTNancy A. Twenhafel
- Joel A. BozueJBJoel A. Bozue
Open Access
- 18 December 2025
- journal article
- Published by Microbiology Society in Microbiology
- Vol. 171 (12) , 001637
Abstract
Tularemia is a zoonotic disease caused by Francisella tularensis . Most human cases are caused by F. tularensis ssp. tularensis (type A) or F. tularensis ssp. holarctica (type B), with the former considered more virulent. For this reason, type A isolates are often the benchmark for the testing of new vaccines or antibiotics. However, both subspecies cause considerable disease and can differ in their responsiveness to medical countermeasures. Accordingly, there is a need to identify and characterize representative type B isolates that are available to qualified research institutions to ensure the development of future vaccines or antibiotics is efficacious against both subspecies. The type B isolate OR96-0246 was identified as a strain that can address this need and was subsequently characterized. For in vitro characterization, the OR96-0246 strain was examined for growth in media and for its ability to form biofilm. As the LPS is an essential virulence factor, the O-antigen was characterized through western analysis. For future medical countermeasure testing for biodefence concerns, pneumonic challenges with animal modelling would be required. Therefore, using the OR96-0246 strain, we implemented animal models that encompassed BALB/c mice, Fischer 344 rats and cynomolgus macaques. Mice were challenged via intranasal instillation with varying doses of OR96-0246, and the LD 50 was determined to be 1 c.f.u. We progressed to Fischer 344 rats, which are a better-suited rodent model to gauge vaccine efficacy. When challenging the rats by whole body aerosolization with various doses of OR96-0246, the LD 50 was determined to be 138 c.f.u. Finally, a staircase challenge design was applied to three cynomolgus macaques, each receiving a different aerosolized dose of OR96-0246 to determine an estimated LD 50 for non-human primates (NHPs). Two out of the three NHPs succumbed to the challenge. The animal that received the lowest dose (2.1×10 4 c.f.u.) survived but did demonstrate clinical signs of infection. Samples from the challenged rats and NHPs were collected for histopathology characterization. Generally, the pathological changes observed in both models were similar, consisting primarily of multifocal bronchopneumonia in the lung and necrotic lesions in the spleen. This animal model development with type B strains of F. tularensis will be essential to properly evaluate new antimicrobials and vaccines to protect against tularemia.Keywords
Funding Information
- DTRA (project # CB11336 & CB11399)
This publication has 116 references indexed in Scilit:
- Implementation of a post-exposure tularemia treatment model for pneumonic challenged Fischer ratsMicrobial Pathogenesis, 2025
- An Emerging Role for Ticks as Vectors of Tularaemia in SwedenVeterinary Medicine and Science, 2024
- First molecular detection of Francisella tularensis in turtle (Testudo graeca) and ticks (Hyalomma aegyptium) in Northwest of IranInternational Journal for Parasitology: Parasites and Wildlife, 2023
- The Natural History of Pneumonic Tularemia in Female Fischer 344 Rats after Inhalational Exposure to Aerosolized Francisella tularensis Subspecies tularensis Strain SCHU S4The American Journal of Pathology, 2017
- Comparison of experimental respiratory tularemia in three nonhuman primate speciesComparative Immunology, Microbiology and Infectious Diseases, 2015
- A rapid one‐step method for the characterization of membrane lipid remodeling in Francisella using matrix‐assisted laser desorption ionization time‐of‐flight tandem mass spectrometryRapid Communications in Mass Spectrometry, 2011
- Toll-like receptor 4 (TLR4) plays a relatively minor role in murine defense against primary intradermal infection with Francisella tularensis LVSImmunology Letters, 2005
- Tularemia as a Biological WeaponJAMA, 2001
- Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium☆Vaccine, 1994
- Tularemia Vaccine StudyArchives of internal medicine (1960), 1961